Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors

Annals of Hematology

Volumn 89, Issue 8, 2010, Pages 813-820

  Woog Kang, Byung ^a   Moon, Joon Ho ^a   Soo Chae, Yee ^a   Gwang Kim, Jong ^a   Jung, Joo Seop ^b   Cho, Goon Jae ^b   Jo, Deog Yeon ^c   Kim, Yeo Kyeoung ^d   Kim, Hyeoung Joon ^d   Ryoo, Hun Mo ^e   Eom, Hyeon Seok ^f   Lee, Sang Min ^g   Lee, Young Don ^g   Won, Jong Ho ^h   Park, Moo Rim ⁱ   Park, Min Kyung ^j   Hyun, Myung Soo ^j   Kyun Sohn, Sang ^a  

^a Kyungpook National University Hospital   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d Chonnam National University Research Institute of Medical Sciences   (South Korea)

^e Catholic University of Daegu   (South Korea)

^f National Cancer Center   (South Korea)

^g Inje University College of Medicine   (South Korea)

^h Soonchunhyang University College of Medicine   (South Korea)

ⁱ Wonkwang University School of Medicine   (South Korea)

^j Yeungnam University College of Medicine   (South Korea)

more..

Author keywords

Graft versus host disease; Matched related donor; Matched unrelated donor; Peripheral blood stem cell transplantation

Indexed keywords

ALEMTUZUMAB; ANTIEMETIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; HLA ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADULT; AGED; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BLOOD DONOR; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CELL COUNT; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE FREE SURVIVAL; FAMILY RELATION; FEMALE; FOLLOW UP; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYCOSIS; MYELODYSPLASTIC SYNDROME; NAUSEA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RELATIVE; RISK FACTOR; SURVIVAL TIME; VOMITING; WHOLE BODY RADIATION; ADOLESCENT; ALLOTRANSPLANTATION; COMPARATIVE STUDY; DONOR; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954677979     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0913-5     Document Type: Article

References (28)

1. de Lima M, Champlin R (2001) Unrelated donor hematopoietic transplantation. Rev Clin Exp Hematol 5:100-134
2. Weisdorf DJ, Anasetti C, Antin JH, Kernan NA, Kollman C, Snyder D, Petersdorf E, Nelson G, McGlave P (2002) Allogeneic bone marrow transplantation for chronic myelogenous leukemia: Comparative analysis of unrelated versus matched sibling donor transplantation. Blood 99:1971-1977
3. Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N, Chehata S, Esperou H, Vernant JP, Michallet M, Buzyn A, Gratecos N, Cahn JY, Bourhis JH, Chir Z, Raffoux C, Socie G, Golmard JL, Jouet JP (2006) Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: A prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 24:5695-5702
4. Hurley CK, Wagner JE, Setterholm MI, Confer DL (2006) Advances in HLA: Practical implications for selecting adult donors and cord blood units. Biol Blood Marrow Transplant 12:28-33
5. Russell JA, Brown C, Bowen T, Luider J, Ruether JD, Stewart D, Chaudhry A, Booth K, Jorgenson K, Coppes MJ, Turner AR, Larratt L, Desai S, Poon MC, Klassen J (1996) Allogeneic blood cell transplants for haematological malignancy: Preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 17:703-708
6. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse- Wilde H (1996) Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88:2775-2779
7. Korbling M, Huh YO, Durett A, Mirza N, Miller P, Engel H, Anderlini P, van Besien K, Andreeff M, Przepiorka D, Deisseroth AB, Champlin RE (1995) Allogeneic blood stem cell transplantation: Peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versushost disease. Blood 86:2842-2848
8. Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLAmatching, and marrow cell dose. Blood 89:4226-4235
9. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15:825-828
10. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204-217
11. Mattsson J (2008) Recent progress in allogeneic stem cell transplantation. Curr Opin Mol Ther 10:343-349
12. Moore J, Nivison-Smith I, Goh K, Ma D, Bradstock K, Szer J, Durrant S, Schwarer A, Bardy P, Herrmann R, Dodds A (2007) Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant 13:601-607
13. Zaucha JM, Gooley T, Bensinger WI, Heimfeld S, Chauncey TR, Zaucha R, Martin PJ, Flowers ME, Storek J, Georges G, Storb R, Torok-Storb B (2001) CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 98:3221-3227
14. Sohn SK, Kim JG, Kim DH, Lee NY, Suh JS, Lee KB (2003) Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation. Bone Marrow Transplant 31:967-972
15. Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE (2006) Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 108:4288-4290
16. Zuckerman T, Rowe JM (2007) Alternative donor transplantation in acute myeloid leukemia: Which source and when? Curr Opin Hematol 14:152-161
17. Chae YS, Sohn SK, Kim JG, Cho YY, Moon JH, Shin HJ, Chung JS, Cho GJ, Yang DH, Lee JJ, Kim YK, Kim HJ (2007) New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: Comparison with BuCy2. Bone Marrow Transplant 40:541-547
18. Champlin RE, Passweg JR, Zhang MJ, Rowlings PA, Pelz CJ, Atkinson KA, Barrett AJ, Cahn JY, Drobyski WR, Gale RP, Goldman JM, Gratwohl A, Gordon-Smith EC, Henslee-Downey PJ, Herzig RH, Klein JP, Marmont AM, O'Reilly RJ, Ringden O, Slavin S, Sobocinski KA, Speck B, Weiner RS, Horowitz MM (2000) T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: Advantage of Tcell antibodies with narrow specificities. Blood 95:3996-4003
19. Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, Przepiorka D, Davies S, Petersen FB, Bartels P, Buell D, Fitzsimmons W, Anasetti C, Storb R, Ratanatharathorn V (2000) Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graftversus- host disease after marrow transplantation from unrelated donors. Blood 96:2062-2068
20. Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373:1550-1561
21. Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, Storb R, Appelbaum FR, Forman SJ, Blume KG, Martin PJ (2002) Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: Long-term follow-up of a randomized trial. Blood 100:415-419
22. Remberger M, Beelen DW, Fauser A, Basara N, Basu O, Ringden O (2005) Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors. Blood 105:548-551
23. Lonnqvist B, Aschan J, Ljungman P, Ringden O (1990) Longterm cyclosporin therapy may decrease the risk of chronic graftversus- host disease. Br J Haematol 74:547-548
24. Young NS, Scheinberg P, Calado RT (2008) Aplastic anemia. Curr Opin Hematol 15:162-168
25. Perez-Simon JA, Sanchez-Abarca I, Diez-Campelo M, Caballero D, San Miguel J (2006) Chronic graft-versus-host disease: Pathogenesis and clinical management. Drugs 66:1041-1057
26. Brunet S, Urbano-Ispizua A, Ojeda E, Ruiz D, Moraleda JM, Diaz MA, Caballero D, Bargay J, de la Rubia J, Solano C, Zuazu J, Diez JL, de la Serna J, Espigado I, Alegre A, Torres JP, Jurado M, Fernandez M, Vivancos P, Carreras E, Hernandez F, Maldonado J, Sierra J, Rozman C (2001) Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies. Br J Haematol 114:544-550
27. Grigg AP, Szer J, Beresford J, Dodds A, Bradstock K, Durrant S, Schwarer AP, Hughes T, Herrmann R, Gibson J, Arthur C, Matthews J (1999) Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia. Br J Haematol 107:409-418
28. Sohn SK, Kim DH, Kim JG, Sung WJ, Baek JH, Lee NY, Won DI, Suh JS, Lee KS, Lee KB (2004) Outcome of allogeneic peripheral blood stem cell transplantation using matched sibling donors in patients with high-risk hematological diseases. Eur J Haematol 72:430-436